विधियों की तुलना करें
चुनी हुई विधियों की आमने-सामने समीक्षा करें; भिन्नता वाली पंक्तियाँ रेखांकित हैं।
| लागत-प्रभावशीलता विश्लेषण (CEA)× | लागत-लाभ विश्लेषण (CBA)× | |
|---|---|---|
| क्षेत्र | स्वास्थ्य अर्थशास्त्र | स्वास्थ्य अर्थशास्त्र |
| परिवार | Process / pipeline | Process / pipeline |
| उद्भव वर्ष≠ | 1984 | 1970s |
| प्रवर्तक≠ | Drummond & Stoddart (Health Economics Research Group, McMaster University) | Boardman, Greenberg, and colleagues (welfare economics) |
| प्रकार | Method | Method |
| मौलिक स्रोत≠ | Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press. link ↗ | Boardman, A. E., Greenberg, D. H., Vining, A. R., & Weimer, D. L. (2018). Cost-Benefit Analysis: Concepts and Practice (5th ed.). Cambridge: Cambridge University Press. link ↗ |
| उपनाम | CEA, ICER, Incremental Cost-Effectiveness Ratio | CBA, economic appraisal, benefit-cost ratio |
| संबंधित | 5 | 5 |
| सारांश≠ | Cost-effectiveness analysis compares the incremental cost per unit of health benefit gained by one intervention relative to a comparator (standard care or best alternative). Developed rigorously in the 1980s by Drummond, Stoddart, and colleagues, CEA is now the standard framework for technology appraisal globally. NICE, HAS, CADTH, and other health technology assessment bodies use CEA to decide which treatments warrant public funding and at what price. | Cost-benefit analysis compares the total monetary value of benefits produced by a program against its total monetary costs, reporting net present value (NPV) or benefit-cost ratio (BCR). Rooted in welfare economics and used extensively in public policy (transportation, environmental, education, health), CBA answers the question: 'Is this program worth doing from a societal perspective?' Unlike cost-effectiveness analysis, CBA monetizes both costs and benefits, enabling comparison across disparate program types. |
| ScholarGateडेटासेट ↗ |
|
|